- Previous Close
3.7700 - Open
3.7700 - Bid 3.6600 x --
- Ask 3.7500 x --
- Day's Range
3.7400 - 3.7700 - 52 Week Range
3.2300 - 5.2000 - Volume
2,139 - Avg. Volume
4,666 - Market Cap (intraday)
140.326M - Beta (5Y Monthly) 0.83
- PE Ratio (TTM)
25.13 - EPS (TTM)
0.1500 - Earnings Date Mar 26, 2025 - Mar 30, 2025
- Forward Dividend & Yield 0.10 (2.92%)
- Ex-Dividend Date May 29, 2024
- 1y Target Est
5.70
H&R GmbH & Co. KGaA engages in the manufacture and sale of chemical-pharmaceutical raw materials and injection molded precision plastic parts. It operates in three segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining segment manufactures and distributes paraffins, white oils, plasticizers, base oils, lubricants, and other crude oil-based specialty products, as well as by-products, such as feedstocks and bunker fuels. The ChemPharm Sales segment processes and distributes plasticizers, wax emulsions, paraffins, and other crude oil-based specialty products. The Plastics segment develops, manufactures, and sells precision plastic parts, components, and medical consumables for medical technology, automotive, and other traditional industries. It provides emulsifiers and bases, waxes and emulsions, petroleum jellies, water-based waxes and oil-emulsions, motor and process oils, cable filling compounds. The company was formerly known as H&R Aktiengesellschaft and changed its name to H&R GmbH & Co. KGaA in August 2016. The company was founded in 1919 and is headquartered in Salzbergen, Germany
www.hur.comRecent News: 2HRA.DE
View MorePerformance Overview: 2HRA.DE
Trailing total returns as of 1/10/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 2HRA.DE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 2HRA.DE
View MoreValuation Measures
Market Cap
140.33M
Enterprise Value
209.40M
Trailing P/E
25.13
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.10
Price/Book (mrq)
0.33
Enterprise Value/Revenue
0.16
Enterprise Value/EBITDA
2.27
Financial Highlights
Profitability and Income Statement
Profit Margin
0.71%
Return on Assets (ttm)
1.94%
Return on Equity (ttm)
2.37%
Revenue (ttm)
1.34B
Net Income Avi to Common (ttm)
9.57M
Diluted EPS (ttm)
0.1500
Balance Sheet and Cash Flow
Total Cash (mrq)
74.63M
Total Debt/Equity (mrq)
50.23%
Levered Free Cash Flow (ttm)
15.57M